Plasma levels of tumor necrosis factor-α correlate with the six-minute walk test results in patients with mild to moderate heart failure

Italian Heart Journal

Volumn 5, Issue 1, 2004, Pages 48-52

  Boffa, Giovanni Maria ^a   Zaninotto, Martina ^a   Nalli, Chiara ^a   Forni, Massimo ^a   Tiso, Enrico ^a   Razzolini, Renato ^a   Plebani, Mario ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Cardiomyopathies; Exercise tolerance; Heart failure

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; TROPONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; EVALUATION; EXERCISE TOLERANCE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; MITRAL VALVE REGURGITATION; MULTIVARIATE ANALYSIS; PHYSIOLOGY; STATISTICS; WALKING;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CORONARY ARTERIOSCLEROSIS; ENDOTHELIN-1; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; SEVERITY OF ILLNESS INDEX; STATISTICS; TROPONIN; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT; WALKING;

EID: 7044253264     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-85.
2. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1347-51.
3. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-16.
4. Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 1999; 20: 1799-807.
5. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (n-brain natriuretic peptide) concentrations. Lancet 2000; 355: 1126-30.
6. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37: 379-85.
7. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001; 37: 386-91.
8. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994; 89: 1580-6.
9. Pacher R, Stanek B, Hulsmann M, et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996; 27: 633-41.
10. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6.
11. Kubota T, Miyagishima M, Alvarez RJ, et al. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant 2000; 19: 819-24.
12. Orus J, Roig E, Perez-Villa F, et al. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 2000; 19: 419-25.
13. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953-8.
14. La Vecchia L, Mezzena G, Ometto R, et al. Detectable serum troponin I in patients with heart failure of non-myocardial ischemic origin. Am J Cardiol 1997; 80: 88-9.
15. Setsuta K, Seino Y, Takahashi N, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999; 84: 608-10.
16. Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J 1999; 138: 95-9.
17. La Vecchia L, Mezzena G, Zanolla L, et al. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 2000; 19: 644-52.
18. Guyatt GH, Sullivan MJ, Thomson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-23.
19. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993; 270: 1702-7.
20. Lucas C, Stevenson LW, Johnson W, et al. The 6-minute walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J 1999; 138: 618-24.
21. Del Ry S, Clerico A, Giannessi D, et al. Measurements of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an IRMA method. Scand J Clin Lab Invest 2000; 60: 81-90.
22. Kim WY, Laterza OF, Hock KG, et al. Performance of a revised cardiac troponin method that minimizes interference from etherophilic antibodies. Clin Chem 2002; 48: 1028-34.
23. Mueller-Bardorff M, Hallermayer K, Schroder A, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43: 458-66.
24. McGeoch G, Lainchbury J, Town GI, et al. Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Fail 2002; 4: 479-83.
25. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-86.
26. Myers J, Gullestad L, Vagelos R, et al. Cardiopulmonary exercise testing and prognosis in severe heart failure - 14 ml/kg/min revisited. Am Heart J 2000; 139: 78-84.